Keytruda 100 MG/4 ML vial 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDJG7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,491
Award facts
- Contract value 100% obligated
- $33,491.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $33,491.48 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. The award was issued on December 10, 2025, with an ultimate completion date of January 2, 2026, and does not include a set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract vehicle awarded on November 13, 2025, that positions the company as a regional prime vendor through 2036.
The PPV-G GEN V program represents a comprehensive $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors capable of supplying diverse pharmaceutical products, including branded and generic prescription medications, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's selection as a prime vendor demonstrates its capability to fulfill specialized pharmaceutical requirements across military healthcare facilities, with the company's established performance on numerous prior delivery orders validating its operational readiness to serve as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FDJG7?
SPE2DR26FDJG7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FDJG7 worth?
The government has obligated $33,491 on SPE2DR26FDJG7.
Is contract SPE2DR26FDJG7 an order under another contract?
Yes. SPE2DR26FDJG7 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJG7 competed?
The extent of competition for SPE2DR26FDJG7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award